Research Summary
Research Summary
11/13/2026
Brian McCurdy
The randomized controlled trial found mobile PrEP and MOUD services did not improve medication use versus peer navigation alone among people who inject drugs, although mortality was lower.
11/13/2026
Research Summary
Research Summary
11/02/2026
Anthony Calabro, MA
AI chatbot engagement was associated with greater PrEP initiation, retention, and appointment attendance in a retrospective US cohort.
11/02/2026
FDA Alert
FDA Alert
10/12/2026
Ashton L. Stahl
The FDA expands dolutegravir treatment to newborns from birth to 4 weeks who weigh at least 2 kg.
10/12/2026
Conference Coverage
Conference Coverage
09/08/2026
Anthony Calabro, MA
No HIV acquisitions occurred among 315 cisgender and transgender women receiving long-acting cabotegravir PrEP in the real-world US OPERA Cohort, despite mostly short injection delays.
09/08/2026
Research Summary
Research Summary
08/13/2026
Ashton L. Stahl
A randomized trial evaluated whether the 4CMenB vaccine prevents gonorrhea among adults at high risk for infection.
08/13/2026
Research Summary
Research Summary
08/06/2026
Ashton L. Stahl
A US prescription claims study evaluated uptake and 2-year persistence among users of long-acting injectable cabotegravir for HIV PrEP.
08/06/2026
Research Summary
Research Summary
07/08/2026
Anthony Calabro, MA
Improving TDF-FTC uptake among US young men who have sex with men on HIV PrEP could yield substantial 10-year value, while a hypothetical study eliminating adverse event uncertainty would not change the...
07/08/2026
Research Summary
Research Summary
04/06/2026
Kate Young
In a phase 3b trial, monthly dapivirine ring and daily oral PrEP were assessed for safety, adherence, and acceptability in pregnancy.
04/06/2026
Research Summary
Research Summary
02/09/2026
Anthony Calabro, MA
A type III hybrid effectiveness–implementation trial compared community-based organization versus direct-to-consumer delivery of the Keep It Up! digital HIV prevention intervention for young men who have...
02/09/2026
Research Summary
Research Summary
01/19/2026
Ashton L. Stahl
A large US cohort study evaluated the scale, patient characteristics, and retention outcomes of telemedicine-delivered HIV preexposure prophylaxis (PrEP), offering clinicians new data on how telePrEP is...
01/19/2026